CN103989754A - Application of wild buckwheat in preparation of medicine for reducing PM2.5 damage to human body - Google Patents
Application of wild buckwheat in preparation of medicine for reducing PM2.5 damage to human body Download PDFInfo
- Publication number
- CN103989754A CN103989754A CN201410241431.7A CN201410241431A CN103989754A CN 103989754 A CN103989754 A CN 103989754A CN 201410241431 A CN201410241431 A CN 201410241431A CN 103989754 A CN103989754 A CN 103989754A
- Authority
- CN
- China
- Prior art keywords
- preparation
- medicine
- damage
- reducing
- human body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses application of wild buckwheat in preparation of a medicine for reducing PM2.5 damage to a human body. Ningning wild buckwheat tablets (capsules) produced by Jinghua Pharmaceutical Co., Ltd. show a good effect on treating PM2.5-induced relevant diseases.
Description
Technical field
The present invention relates to a kind of Cymose buckwheat rhizome preparation and reduce PM2.5 to the application in harm medicine in preparation.
Background technology
Haze is the portmanteau word of mist and haze.Haze weather frequently occurs, harm people's cardiopulmonary cause lower respiratory infection and heart disease to increase.The main arch-criminal of haze is PM2.5, the particulate matter that diameter is less than 2.5 microns.Once PM2.5 is sucked by human body, will stimulate and destroy respiratory mucosa, make nasal cavity become dry, destroy respiratory mucosa defence capability, antibacterial enters respiratory tract, easily causes upper respiratory tract infection.Haze more easily causes the discomfort such as breathe hard, uncomfortable in chest for the crowd who suffers from the respiratory system diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease, may cause pulmonary infection, or occurs acute exacerbation reaction.
Summary of the invention
The object of the present invention is to provide a kind of eutherapeutic Cymose buckwheat rhizome preparation to reduce PM2.5 in preparation applies in to harm medicine.
Technical solution of the present invention is:
A kind of Cymose buckwheat rhizome preparation reduces PM2.5 in preparation and applies in to harm medicine.
Described Cymose buckwheat rhizome preparation is Rhizoma Fagopyri Dibotryis sheet or capsule.
The secret prescription handed down in the family from generation to generation that Rhizoma Fagopyri Dibotryis sheet becomes Yunlong to dedicate in 1958 as famous old docter of TCM, lung abscess expert, has the effect for the treatment of lung abscess.The relevant disease that the present invention uses peaceful board Rhizoma Fagopyri Dibotryis sheet (capsule) the treatment PM2.5 of Jinghua Pharmaceutical Group Co., Ltd.'s production to cause has been obtained good effect.
Model case:
Zhang, man, 57 years old, body weight 60kg, height 175cm.There is chronic bronchitis history.Due to the haze weather of continuous several days, PM2.5 sucked more, patient feels to breathe hard, uncomfortable in chest, breathe and have some setbacks, after pharynx, have wall mucus adhering sense.Therapeutic Method: take the peaceful board Rhizoma Fagopyri Dibotryis sheet (specification: 15 * 2/ capsules that Jinghua Pharmaceutical Group Co., Ltd. produces.), oral, a 4-5 sheet, 3 times on the one.5 days courses for the treatment of.Take medicine after 2 days, patient has black expectorant to discharge.Take medicine after 2 courses for the treatment of, patient's symptom is clearly better, and discharges without black expectorant.
Lee, female, 45 years old, body weight 49kg, height 159cm.Due to the haze weather of continuous several days, there is part PM2.5 to suck, that patient feels is uncomfortable in chest, breathe and have some setbacks, and has wall mucus adhering sense after pharynx.Therapeutic Method: take the peaceful board Rhizoma Fagopyri Dibotryis capsule (specification: 12 * 3/ capsules that Jinghua Pharmaceutical Group Co., Ltd. produces.), oral, one time 3,3 times on the one.5 days courses for the treatment of.Take medicine after 1 day, patient has black expectorant to discharge.Take medicine after 1 course for the treatment of, patient's symptom is clearly better, and after pharynx, without wall mucus adhering sense, without sense uncomfortable in chest, breathe smooth and easyly, discharges without black expectorant.
Below in conjunction with embodiment, the invention will be further described.
Detailed description of the invention
A kind of Cymose buckwheat rhizome preparation reduces PM2.5 in preparation and applies in to harm medicine.
Described Cymose buckwheat rhizome preparation is peaceful board Rhizoma Fagopyri Dibotryis sheet or the capsule that Jinghua Pharmaceutical Group Co., Ltd. produces.
Claims (2)
1. a Cymose buckwheat rhizome preparation reduces PM2.5 in preparation and applies in to harm medicine.
2. Cymose buckwheat rhizome preparation according to claim 1 reduces PM2.5 in preparation and applies in to harm medicine, it is characterized in that: described Cymose buckwheat rhizome preparation is Rhizoma Fagopyri Dibotryis sheet or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410241431.7A CN103989754A (en) | 2014-06-03 | 2014-06-03 | Application of wild buckwheat in preparation of medicine for reducing PM2.5 damage to human body |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410241431.7A CN103989754A (en) | 2014-06-03 | 2014-06-03 | Application of wild buckwheat in preparation of medicine for reducing PM2.5 damage to human body |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103989754A true CN103989754A (en) | 2014-08-20 |
Family
ID=51304255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410241431.7A Pending CN103989754A (en) | 2014-06-03 | 2014-06-03 | Application of wild buckwheat in preparation of medicine for reducing PM2.5 damage to human body |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103989754A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107029063A (en) * | 2017-05-08 | 2017-08-11 | 浙江农林大学 | A kind of haze that reduces is to the Chinese medicine composition that is damaged caused by respiratory tract and lung |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1448174A (en) * | 2003-05-03 | 2003-10-15 | 南通精华制药有限公司 | Application of cymose buckwheat rhizome in preparation of antiviral drug |
-
2014
- 2014-06-03 CN CN201410241431.7A patent/CN103989754A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1448174A (en) * | 2003-05-03 | 2003-10-15 | 南通精华制药有限公司 | Application of cymose buckwheat rhizome in preparation of antiviral drug |
Non-Patent Citations (3)
| Title |
|---|
| 张丽蓉等: "金荞麦片治疗儿童呼吸道感染46例", 《中国中医急症》 * |
| 揭金阶等: "《临床中成药物学》", 31 October 2004, 湖北科学技术出版社 * |
| 财富在线: "雾霾天催涨中药概念 精华制药抗霾药受到追捧", 《HTTP://STOCK.CNCFZX.COM/A/20131227/1146927.HTML》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107029063A (en) * | 2017-05-08 | 2017-08-11 | 浙江农林大学 | A kind of haze that reduces is to the Chinese medicine composition that is damaged caused by respiratory tract and lung |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103989927A (en) | Traditional Chinese medicine preparation for treating pharyngolaryngitis and preparation method thereof | |
| CN103961533A (en) | Traditional Chinese medicine atomizing agent for treating pharyngitis | |
| CN102641394B (en) | Traditional Chinese medicine composite for treating allergic rhinitis | |
| CN103989754A (en) | Application of wild buckwheat in preparation of medicine for reducing PM2.5 damage to human body | |
| CN103638488B (en) | One treats pleuritic Chinese medicine composition | |
| CN101152254A (en) | Traditional Chinese medicine for treating chronic and allergic rhinitis | |
| CN104474310A (en) | Traditional Chinese medicine composition for treating cough as well as preparation method and application of traditional Chinese medicine composition | |
| CN102451254B (en) | Medicine for treating emphysema | |
| CN104666910A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN103977234A (en) | Pseudostellaria root cough-relieving and asthma-calming traditional Chinese medicine preparation | |
| CN103989929A (en) | Traditional Chinese medicine preparation for treating pharyngolaryngitis and preparation method thereof | |
| CN103599183A (en) | Chinese and western medicine composition for treating anaphylactic rhinitis | |
| CN103099877B (en) | Traditional Chinese medicine formula for treating and preventing children asthmatic disease | |
| CN103623389B (en) | A kind of Chinese medicine composition for the treatment of wind-cold type infantile bronchitis | |
| CN105596467A (en) | Children cough treating traditional Chinese medicine formula | |
| CN102949638A (en) | Traditional Chinese medicine formula for treating asthma | |
| CN104873658A (en) | Traditional Chinese medicine composition for treating wind-heat affecting lung type cough | |
| CN105327055A (en) | Cudweed combined medicine for treating chronic bronchial asthma | |
| CN105327130A (en) | Traditional Chinese medicine composition for treating upper airway cough syndromes and nursing method | |
| CN106266499A (en) | A kind of formula controlling cough out of breath | |
| CN104435290A (en) | Traditional Chinese medicine pill for treating acute upper respiratory infection | |
| CN104337942A (en) | Chinese medicinal pills for treating chronic bronchitis | |
| CN103341000B (en) | One treats bronchitic Chinese medicine | |
| CN103751513B (en) | One is treated emophysematous Chinese medicine composition | |
| CN103263550B (en) | Traditional Chinese medicine for upper respiratory tract infection treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140820 |